Tg(APOE-NPC1L1)112Lqyu
Transgene Detail
|
|
| Symbol: |
Tg(APOE-NPC1L1)112Lqyu |
| Name: |
transgene insertion 112, Liqing Yu |
| MGI ID: |
MGI:4822042 |
| Synonyms: |
L1-Tg112, NPC1L1-Tg-High |
| Transgene: |
Tg(APOE-NPC1L1)112Lqyu Location: unknown
|
| Alliance: |
Tg(APOE-NPC1L1)112Lqyu page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Tg(APOE-NPC1L1)112Lqyu expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Homolog in Mouse |
Note |
| human |
NPC1L1 (29881) |
|
|
|
| |
|
Mutation details: A transgenic construct containing the human NPC1 (Niemann-Pick disease, type C1, gene)-like 1 (NPC1L1) gene under the control of the human apolipoprotein E (APOE) promoter and hepatic control region was injected into fertilized B6D2F1/Hsd mouse eggs. Two lines were established, L1-Tg20 and L1-Tg112. Transgene expression is detected in liver by Western blot analysis and is localized to the canalicular membrane.
(J:124193)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:163160 Temel RE, et al., Biliary sterol secretion is not required for macrophage reverse cholesterol transport. Cell Metab. 2010 Jul 4;12(1):96-102 |
| All: |
4 reference(s) |
|